Glioblastoma (GBM) is among the most aggressive and lethal brain tumors, and standard treatment offers only modest survival benefits. Chimeric antigen receptor (CAR) T cell therapy has transformed the treatment of hematologic cancers, but its efficacy in GBM remains limited. Here we develop a CAR-engineered microglia (...
Museog Choe, W. Yang, Bilal Cakir et al.· Cell Reports· 0 citations
This work shows that a DEAF1 mutation in human embryonic stem cells disrupts chromatin accessibility at neuronal gene loci, leading to significant transcriptional alterations, and identifies WNT signaling, TGFβ superfamily signaling, and cell cycle regulation as commonly dysregulated pathways across multiple ASD-associ...
Jonghun Kim, Museog Choe, W. Yang et al.· Science Advances· 1 citation
Findings identify plaque-associated oligodendrocyte proteostatic failure as a candidate mechanism of myelin loss and a potential therapeutic pathway in AD and restores MBP protein levels and improves compact myelin ultrastructure in AD organoids.
Jong Shin, Nandita Joshi, Brendan F. Miller et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.